Cargando…

Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives

Detalles Bibliográficos
Autores principales: Evans, D Gareth R, Howell, Anthony, Ingham, Sarah L, Buchan, Iain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672730/
https://www.ncbi.nlm.nih.gov/pubmed/23448362
http://dx.doi.org/10.1186/bcr3382
_version_ 1782272162019672064
author Evans, D Gareth R
Howell, Anthony
Ingham, Sarah L
Buchan, Iain
author_facet Evans, D Gareth R
Howell, Anthony
Ingham, Sarah L
Buchan, Iain
author_sort Evans, D Gareth R
collection PubMed
description
format Online
Article
Text
id pubmed-3672730
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36727302013-08-26 Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives Evans, D Gareth R Howell, Anthony Ingham, Sarah L Buchan, Iain Breast Cancer Res Letter BioMed Central 2013 2013-02-26 /pmc/articles/PMC3672730/ /pubmed/23448362 http://dx.doi.org/10.1186/bcr3382 Text en Copyright © 2013 BioMed Central Ltd
spellingShingle Letter
Evans, D Gareth R
Howell, Anthony
Ingham, Sarah L
Buchan, Iain
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
title Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
title_full Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
title_fullStr Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
title_full_unstemmed Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
title_short Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
title_sort contralateral breast cancer risk in brca1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672730/
https://www.ncbi.nlm.nih.gov/pubmed/23448362
http://dx.doi.org/10.1186/bcr3382
work_keys_str_mv AT evansdgarethr contralateralbreastcancerriskinbrca12positivefamiliesneedstobeadjustedforphenocopyratesparticularlyinseconddegreeuntestedrelatives
AT howellanthony contralateralbreastcancerriskinbrca12positivefamiliesneedstobeadjustedforphenocopyratesparticularlyinseconddegreeuntestedrelatives
AT inghamsarahl contralateralbreastcancerriskinbrca12positivefamiliesneedstobeadjustedforphenocopyratesparticularlyinseconddegreeuntestedrelatives
AT buchaniain contralateralbreastcancerriskinbrca12positivefamiliesneedstobeadjustedforphenocopyratesparticularlyinseconddegreeuntestedrelatives